logo

publication ethics

Publication Ethics and Publication Malpractice Statement
Last Updated: September 2024

 


1. Introduction
2. Editorial Responsibilities
2.1. Publication Decisions
2.2. Confidentiality
2.3. Disclosure and Conflicts of Interest
2.4. Corrections and Retractions
3. Reviewer Responsibilities
3.1. Contribution to Editorial Decisions
3.2. Promptness
3.3. Confidentiality
3.4. Objectivity Standards
3.5. Acknowledgement of Sources
3.6. Disclosure and Conflict of Interest
4. Author Responsibilities
4.1. Reporting Standards
4.2. Data Access and Retention
4.3. Originality and Plagiarism
4.4. Multiple, Redundant, or Concurrent Publication
4.5. Authorship Criteria
4.6. Disclosure and Conflicts of Interest
4.7. Fundamental Errors in Published Works
4.8. Ethical Approvals
4.9. AI-Assisted Technology Disclosure
5.Journal Policies
5.1. Misconduct Handling
5.2. Preprint Policy
5.3. Clinical Trial Registration
5.4. Patient Consent and Confidentiality
6. References

1
1. Introduction
The Preventive Care in Nursing and Midwifery Journal (PCNM) is committed to maintaining the highest standards of publication ethics and takes all possible measures against publication malpractice. This statement is based on the Committee on Publication Ethics (COPE) Code of Conduct and Best Practice Guidelines for Journal Editors (current version), and we follow COPE flowcharts for dealing with cases of suspected misconduct.

2

2. Editorial Responsibilities
2.1. Publication Decisions
The Editor-in-Chief is responsible for deciding which submitted articles should be published. These decisions are based on the article's importance, originality, clarity, and relevance to the journal's scope, without regard to authors' race, gender, sexual orientation, religious beliefs, ethnic origin, citizenship, or political philosophy. Legal requirements regarding libel, copyright infringement, and plagiarism are carefully considered.
2.2. Confidentiality
Editors and editorial staff must maintain confidentiality regarding submitted manuscripts and must not disclose any information about submissions to anyone other than corresponding authors, reviewers, potential reviewers, or other editorial advisors.
2.3. Disclosure and Conflicts of Interest
Unpublished materials disclosed in submitted manuscripts must not be used in the editors' own research without explicit written consent from the authors. Editors recuse themselves from considering manuscripts in which they have conflicts of interest.
2.4. Corrections and Retractions
When errors are identified in published articles, the journal will:
  • Publish correction notices detailing changes and citing the original publication
  • Post updated article versions with change documentation
  • Archive all prior versions of the article
  • Ensure proper indexing of corrections
3
3. Reviewer Responsibilities
3.1. Contribution to Editorial Decisions
Peer review assists editors in making editorial decisions and may help authors improve their manuscripts through constructive feedback.
3.2. Promptness
Reviewers who feel unqualified to review research or cannot promptly complete their review should immediately notify editors and withdraw from the process.
3.3. Confidentiality
All manuscripts received for review must be treated as confidential documents and must not be shown to or discussed with others except as authorized by the editor.
3.4. Objectivity Standards
Reviews should be conducted objectively, with no personal criticism of authors. Referees should express views clearly with supporting arguments.
3.5. Acknowledgement of Sources
Reviewers should identify relevant published work that has not been cited by authors and alert editors to any substantial similarity or overlap between the manuscript under consideration and any other published paper.
3.6. Disclosure and Conflict of Interest
Privileged information obtained through peer review must remain confidential. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from relationships with authors, companies, or institutions connected to the papers.

4

4. Author Responsibilities
4.1. Reporting Standards
Authors must present accurate accounts of original research and objective discussions of significance. Underlying data should be represented accurately, with sufficient detail and references to permit replication.
4.2. Data Access and Retention
Authors may be asked to provide raw data for editorial review and should be prepared to provide public access to such data when practicable, retaining data for at least ten years after publication.
4.3. Originality and Plagiarism
Authors must ensure their work is entirely original, and must appropriately cite or quote the work of others. Publications that have influenced the research should be properly acknowledged.
4.4. Multiple, Redundant, or Concurrent Publication
Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior. Manuscripts that have been published as copyrighted material elsewhere cannot be submitted.
4.5. Authorship Criteria
Authorship should be limited to those who have made significant contributions to conception, design, execution, or interpretation of the reported study. All co-authors must approve the final version and agree to its submission. PCNM follows the ICMJE criteria for authorship:
  1. Substantial contributions to conception/design, or data acquisition/analysis/interpretation
  2. Drafting or critically revising the article
  3. Final approval of the version to be published
      4. Agreement to be accountable for all aspects of the work
​​​​​​
4.6. Disclosure and Conflicts of Interest
All authors must disclose:
  • Financial or other substantive conflicts of interest
  • All sources of financial support
  • The role of funders in research design, data collection, analysis, and reporting
  • Whether authors had access to study data
4.7. Fundamental Errors in Published Works
When authors discover significant errors in their published work, they must promptly notify the journal and cooperate to retract or correct the paper.
4.8. Ethical Approvals
Studies involving human subjects must include:
  • Ethical approval statement with committee name and approval code
  • Informed consent statement
  • Compliance with the Declaration of Helsinki
Animal studies must comply with international welfare guidelines and include approval statements.
4.9. AI-Assisted Technology Disclosure
Authors must transparently report the use of AI and AI-assisted technologies in manuscript preparation, including:
  • Name and version of AI tool
  • Specific purpose of use
  • Ethical violations
5
5. Journal Policies
5.1. Misconduct Handling
PCNM follows COPE flowcharts when dealing with suspected misconduct including:
  • Plagiarism
  • Data fabrication/falsification
  • Authorship disputes
  • Duplicate publication
  • Ethical violations
5.2. Preprint Policy
PCNM allows submission of manuscripts previously posted on preprint servers. Authors must disclose this during submission.
5.3. Clinical Trial Registration
Clinical trials must be registered in publicly accessible registries before participant recruitment.
5.4. Patient Consent and Confidentiality
Authors must protect patient anonymity and include statements confirming patient consent for publication where appropriate.

6

6. References
  1. Committee on Publication Ethics (COPE). (2024). Code of Conduct and Best Practice Guidelines for Journal Editors. Retrieved from  https://publicationethics.org/resources/code-conduct
  2. International Committee of Medical Journal Editors (ICMJE). (2024). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Retrieved from  http://www.icmje.org/recommendations
  3. World Medical Association. (2013). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310(20), 2191-2194.

For concerns about potential misconduct or ethical issues, please contact the editorial office at pcnmzums.ac.ir, pcnmjournalgmail.com


View: 13025 Time(s)   |   Print: 2471 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)